|
13 Jan 2020 |
Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates
|
|
13 Jan 2020 |
Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog
|
|
13 Jan 2020 |
Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement
|
|
13 Jan 2020 |
Bayer and Daré Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene®
|
|
13 Jan 2020 |
Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc.
|
|
13 Jan 2020 |
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab (news with additional features)
|
|
12 Jan 2020 |
Serimmune and Atreca, Inc. Establish Research Collaboration Agreement in Oncology
|
|
12 Jan 2020 |
Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases
|
|
12 Jan 2020 |
Amunix Pharmaceuticals Announces Technology Licensing Agreement with Roche to Advance Novel Therapeutics Outside Oncology
|
|
12 Jan 2020 |
Bayer and Azitra partner to harness the human skin microbiome as a source for new natural skin care products for sensitive and eczema-prone skin
|
|
11 Jan 2020 |
Lilly Announces Agreement to Acquire Dermira
|
|
10 Jan 2020 |
Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery
|
|
09 Jan 2020 |
Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies
|
|
09 Jan 2020 |
CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute enter into a partnership to develop iPSC derived CAR NK Therapeutics
|
|
09 Jan 2020 |
eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-in-Class Inhibitors of eIF4E to Treat Multiple Cancer Types
|
|
09 Jan 2020 |
Kaleido Biosciences Announces Collaboration with Janssen to Explore the Potential for Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions by Promoting Healthy Function of the Gut Microbiome
|
|
09 Jan 2020 |
Aro Biotherapeutics and Ionis Enter Licensing and Collaboration Agreement Focused on Cell-Specific Delivery of Antisense Oligonucleotides
|
|
09 Jan 2020 |
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases
|
|
09 Jan 2020 |
Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University
|
|
09 Jan 2020 |
Immunic Exercises its Option for the Exclusive Worldwide License to IMU-856 from Daiichi Sankyo Co., Ltd.
|
|
09 Jan 2020 |
Bayer and Evotec form new strategic alliance focusing on polycystic ovary syndrome
|
|
09 Jan 2020 |
Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies
|
|
09 Jan 2020 |
Altavant Sciences Acquires Onspira Therapeutics, Adding a Potentially Life-Saving Treatment for Post-Lung Transplant Patients to the Altavant Pipeline
|
|
09 Jan 2020 |
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
|
|
09 Jan 2020 |
SAB Biotherapeutics Announces Research Collaboration With CSL Behring
|
